Safety, tolerability and pharmacokinetics of GSK3008348, a novel integrin αvβ6 inhibitor, in healthy participants.

Saved in:
Bibliographic Details
Title: Safety, tolerability and pharmacokinetics of GSK3008348, a novel integrin αvβ6 inhibitor, in healthy participants.
Authors: Maden CH; Projects Clinical Platforms and Sciences, GSK, Uxbridge, Middlesex, UK., Fairman D; Clinical Pharmacology Modelling and Simulation, GSK, Stevenage, Hertfordshire, UK., Chalker M; Global Clinical Safety and Pharmacovigilance, GSK, Uxbridge, Middlesex, UK., Costa MJ; Clinical Statistics, GSK, Stevenage, Hertfordshire, UK., Fahy WA; Respiratory Therapy Area, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, UK., Garman N; Projects Clinical Platforms and Sciences, GSK, Uxbridge, Middlesex, UK., Lukey PT; Respiratory Therapy Area, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, UK., Mant T; QuintilesIMS, Reading, Berkshire, UK., Parry S; Platform Technology and Science, GSK, Ware, Hertfordshire, UK., Simpson JK; Respiratory Therapy Area, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, UK., Slack RJ; Respiratory Therapy Area, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, UK., Kendrick S; Respiratory Therapy Area, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, UK., Marshall RP; Respiratory Therapy Area, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, UK. richard.p.marshall@gsk.com.
Source: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2018 Jun; Vol. 74 (6), pp. 701-709. Date of Electronic Publication: 2018 Mar 12.
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041 (Electronic) Linking ISSN: 00316970 NLM ISO Abbreviation: Eur J Clin Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1432-1041
DOI:10.1007/s00228-018-2435-3